Código QR (código de barras bidimensional)

Early costs and complications of first-line low-grade glioma treatment using a large national database: Limitations and future perspectives

IntroductionDiffuse Low-grade gliomas (DLGG, WHO Grade II) are a heterogenous group of tumors comprising 13–16% of glial tumors. While maximal safe resection is endorsed as the best approach to DLGG, compared to more conservative interventions like stereotactic biopsy, the added costs and risks have...

תיאור מלא

שמור ב:
Principais autores: Kyle Tuohy, Djibril M. Ba, Debarati Bhanja, Douglas Leslie, Guodong Liu, Alireza Mansouri
פורמט: Artigo
שפה:Inglês
יצא לאור: Frontiers Media S.A. 2023-02-01
סדרה:Frontiers in Surgery
נושאים:
low-grade glioma (WHO grade II)
cost
resection
stereotactic biopsy
adverse events—complications
MarketScan database
גישה מקוונת:https://www.frontiersin.org/articles/10.3389/fsurg.2023.1001741/full
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים